Operator
Good morning, ladies and gentlemen. Thank you for joining us for TherapeuticsMD fourth-quarter 2020 financial results conference call. [Operator instructions] I would now like to turn the call over to TherapeuticsMD's Vice President of Investor Relations Nichol Ochsner. Nichol?
Nichol Ochsner --
Vice President, Investor Relations
Thank you. Good morning, everyone. Thank you for joining today to discuss our fourth-quarter financial results and business update. This morning, TherapeuticsMD issued a press release announcing our fourth-quarter financial results.
The press release is available on the company's website, therapeuticsmd.com in the investors and media section. On today's call from TherapeuticsMD are Chief Executive Officer Robert Finizio, Chief Financial Officer James D'Arecca, Chief Commercial Officer Dawn Halkuff, and Chief Strategy and Performance Officer Mitchell Krassan. I would like to remind everyone that certain statements made during this conference call may contain forward-looking statements. Such forward-looking statements are based upon current expectations, and there can be no assurance that the results contemplated in these statements will be realized.